- Home
- PSF vs PROF Comparison
PSF vs PROF Comparison
Compare PSF & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSF
- PROF
- Stock Information
- Founded
- PSF 2010
- PROF N/A
- Country
- PSF United States
- PROF Canada
- Employees
- PSF N/A
- PROF N/A
- Industry
- PSF Investment Managers
- PROF Medical/Dental Instruments
- Sector
- PSF Finance
- PROF Health Care
- Exchange
- PSF Nasdaq
- PROF Nasdaq
- Market Cap
- PSF 242.7M
- PROF 186.3M
- IPO Year
- PSF N/A
- PROF N/A
- Fundamental
- Price
- PSF $19.70
- PROF $7.24
- Analyst Decision
- PSF
- PROF Strong Buy
- Analyst Count
- PSF 0
- PROF 2
- Target Price
- PSF N/A
- PROF $11.40
- AVG Volume (30 Days)
- PSF 25.0K
- PROF 106.8K
- Earning Date
- PSF 01-01-0001
- PROF 11-07-2024
- Dividend Yield
- PSF 7.69%
- PROF N/A
- EPS Growth
- PSF N/A
- PROF N/A
- EPS
- PSF N/A
- PROF N/A
- Revenue
- PSF N/A
- PROF $8,984,000.00
- Revenue This Year
- PSF N/A
- PROF $56.61
- Revenue Next Year
- PSF N/A
- PROF $160.87
- P/E Ratio
- PSF N/A
- PROF N/A
- Revenue Growth
- PSF N/A
- PROF 39.35
- 52 Week Low
- PSF $16.00
- PROF $6.88
- 52 Week High
- PSF $20.19
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- PSF 21.41
- PROF 40.10
- Support Level
- PSF $20.32
- PROF $7.00
- Resistance Level
- PSF $20.24
- PROF $7.40
- Average True Range (ATR)
- PSF 0.17
- PROF 0.40
- MACD
- PSF -0.08
- PROF -0.07
- Stochastic Oscillator
- PSF 0.00
- PROF 15.52
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.